Group 1 - The article highlights the success of Tuoxin Pharmaceutical Group under the leadership of Chairman Yang Xining, emphasizing the company's journey from a technology-driven startup to a leading player in the pharmaceutical industry, culminating in its successful listing on the capital market [2] - Yang Xining's focus on core technologies, particularly in the field of nucleoside (acid) raw materials and pharmaceutical intermediates, has established Tuoxin Pharmaceutical as a leader in this high-barrier segment, with a comprehensive product chain covering various therapeutic areas [3] - The company has implemented international quality standards, achieving ISO9001 certification and GMP management for raw material production, which has facilitated its global market entry and product registration in countries like India and Uzbekistan [5] Group 2 - Under Yang Xining's leadership, Tuoxin Pharmaceutical has received multiple awards for its scientific contributions, including the "National Science and Technology Progress Award" and recognition as a "National High-tech Industry Demonstration Project," showcasing its research and industrial transformation capabilities [6] - Yang Xining actively engages in social responsibility and industry development, contributing to regional economic growth and fostering talent through academic collaborations and mentorship roles [8] - The successful listing of Tuoxin Pharmaceutical on the Shenzhen Stock Exchange in October 2021 marks a significant milestone, reflecting the company's robust development and setting the stage for future growth through capital market leverage [8]